Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
4.740
+0.040 (0.85%)
Dec 20, 2024, 4:00 PM EST - Market closed
Adverum Biotechnologies Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for ADVM stock have an average target of 27.83, with a low estimate of 10 and a high estimate of 40. The average target predicts an increase of 487.13% from the current stock price of 4.74.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 19, 2024.
Analyst Ratings
The average analyst rating for ADVM stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +532.91% | Nov 19, 2024 |
RBC Capital | RBC Capital | Hold Maintains $12 → $10 | Hold | Maintains | $12 → $10 | +110.97% | Nov 5, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $60 → $40 | Strong Buy | Maintains | $60 → $40 | +743.88% | Aug 14, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +532.91% | Aug 13, 2024 |
RBC Capital | RBC Capital | Hold Maintains $15 → $12 | Hold | Maintains | $15 → $12 | +153.16% | Aug 13, 2024 |
Financial Forecast
Revenue This Year
1.02M
from 3.60M
Decreased by -71.67%
Revenue Next Year
14.72M
from 1.02M
Increased by 1,342.84%
EPS This Year
-5.11
from -11.62
EPS Next Year
-4.77
from -5.11
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 1.1M | 105.0M | 948,150 | |||
Avg | 1.0M | 14.7M | 460,530 | |||
Low | 980,000 | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -70.8% | 10,194.1% | -93.6% | |||
Avg | -71.7% | 1,342.8% | -96.9% | |||
Low | -72.8% | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -4.85 | -0.22 | -0.18 | |||
Avg | -5.11 | -4.77 | -4.25 | |||
Low | -5.30 | -6.08 | -6.42 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.